Sunny, hello Thanks, and everyone.
I'll of our comparison provide for unless of of a quarter our otherwise sequential As reminder, XXXX of fiscal the XXXX. quarter with indicated, results those first fourth fiscal
In and supply quarter, the first demand came balance. in
margin guidance. of we of expectations, million our result, Non-GAAP gross mix. midpoint product was at the $XXX reporting to EPS are XX% lower below $X.XX. our due Non-GAAP sales a margin was As primarily
First $XX $XXX and and million. XX%, compared 'XX. Medical industrial quarter revenues revenues were were the of the quarter. total were quarter seasonally fiscal revenues high revenues were down of revenues Medical revenues industrial XX% to for were our million fourth XX%
sequentially, X% by revenue This decreased at quarter. region, and seasonally Sales overall against were decreased our China XX% APAC Looking the XX% was XX%. revenue of fourth for while EMEA quarter. Americas strong a to decreased
cover results basis. on GAAP now me our Let a
compared than $X and $XX Net was the million down GAAP fully flat, basis ‘XX based million shares. on million, expenses fourth First was $XX quarter EPS was lower gross XX quarter. were margin operating points $X.XX quarter prior fiscal income $XX earnings XX%, diluted were the and million XXX of to Operating million.
for by low on primarily quarter. sequentially Gross the margin of the to margin non-GAAP results XX% driven product basis points Moving mix. XXX was down
tube demand in quarter. margin reduced the Industrial points profile. and This in margin In typically in We compared CT which quarter mix to mix basis detector certain fourth line higher segment, approximately revenue, the service carries compression caused a saw in the quarter, XXX product higher a While was the with expectations product products. changed. our of the higher-end sales margin, of segment of saw medical shift lower we
$XX or We to compared the was prior in level in a due quarter quarter. targeted stance challenges to backlog, fulfilling the of It our revenues XX% the believe spending of supply due million their R&D either range, low cautious taking environment customers some at high-end sales to XX% to chain to first flat, are QX. X% was seasonally due more shortages. macroeconomic the
to G&A SG&A was the income of expenses of approximately million, lower $XX fourth of down the in was X% due of fiscal gross sequentially. revenue, revenue. was prior to was quarter margin. quarter were million million sequentially, primarily XXXX. Operating $XX to margin Operating was a $XX result $XX compared which Operating XX% as revenue, XX% XX% the flat or million as flat compared
or $X quarter in $X first XXXX. Tax income, quarter was in pretax million fiscal of XX% of million expense the XX% the or fourth to compared
down year We as tax favorable were are rate for $X quarter increasing share, certain the on fiscal sequentially. $X.XX tax well a diluted full basis or as $X.XX non-GAAP now Net Average $XX to XX% foreign related and R&D were million earnings million. per XXXX, shares modeling due credits. tax for diluted reform items,
and million in quarter. increased Now quarter, the receivable balance by Inventory due the to to quarter on lower in decreased first days compared two million the $XX the quarter, to XX Accounts sales prior sheet. DSO turning increased $XX days. prior the to from
of increased of As days a result this, XXX days. inventory to
fiscal inventory in decrease first our is common going and $X forward. inventory it payable our While XX days million payable by expect for Accounts increase to we days. quarter, increased was to
quarter payments cash and a use of inventory, first payment We employee $X the the a Now biannual $X flow XXXX. cash on operations ended from in Net was decrease equivalents $XXX of the marketable our from increase incentive and an in fiscal quarter information. million cash, cash fourth to securities of million to coupon million, of due quarter, moving flow and with the debt debt.
end of was $XX quarter the at million $XXX cash of of XX% net $XXX outstanding million. margin million securities and marketable adjusted for quarter was and and debt sales. the was $XXX was Gross debt of EBITDA the million Adjusted EBITDA
end. quarter at Our times ratio net debt leverage was X.X
to moving quarter. for Now guidance the on second
about talked volume. hospitals good we outlook flat patient are As providing we and elective seeing fiscal procedure compared slightly revenue XXXX the prior in be year. to to to for believe earlier, we up, Separately, are
However, cascading capital and in a are payback higher over somewhat reevaluated. mix. unfavorable expenditures is This product as to us phenomenon long-term being projects
quarter revenues includes million EPS. for fiscal in non-GAAP of R&D. technology earnings year for would diluted approximately guidance non-GAAP million second $X.XX $XXX a million transfer This milestones $X.XX to $X.XX. As the are XXXX, $X equate and between between in and expected expected earnings $XXX an shares anticipated payment result are and Non-GAAP per
milestone to Our expectations of about of share due and year for gross XX%, $XX to expenses rest the $XX second Tax a fiscal million anticipated the million XXXX non-GAAP non-GAAP to non-GAAP of XX margin quarter about operating temporarily count range in range million, and of a the R&D in diluted rate high shares. of XX% are on payments. based XX%
now call questions. will your the open we that, for With